BASF SE earnings call: strategy advances amid headwinds

BASF SE ((BASFY)) has held its Q4 earnings call. Read on for the main highlights of the call.

BASF’s latest earnings call painted a mixed picture for investors. Management highlighted major strategic wins and tighter financial discipline, yet repeatedly stressed that 2026 will be a tough, transitional year marked by margin pressure, FX headwinds, and only gradual demand recovery, especially in chemicals and in an oversupplied China.

Zhanjiang start-up delivers on time but earnings lag

BASF completed the full start-up of its Zhanjiang Verbund site, bringing all 32 production lines and the steam cracker online on time and below budget with flexible feedstock options. The site will likely weigh slightly on earnings in its first year, with management only expecting a positive contribution from 2027 as volumes ramp and margins recover.

Agricultural Solutions shines and moves toward IPO

Agricultural Solutions remained a bright spot, posting an EBITDA margin before special items of 22% and underlining its resilience in a weaker macro environment. BASF is progressing with legal and ERP separation to prepare the business for a potential IPO in 2027, bolstered by the planned AgBiTech acquisition to strengthen biological crop protection.

MDI expansion signals long-term confidence in U.S.

In performance materials, BASF is pressing ahead with its USD 1 billion MDI expansion in Geismar, its largest investment in the U.S. to date. The project will roughly double MDI capacity to about 600,000 metric tons per year, with start-up slated for the third quarter of 2026 to capture future demand in insulation and construction.

Portfolio reshaping with high-value Coatings deal

Portfolio moves accelerated as BASF completed the sale of its Decorative Paints business and agreed to sell Coatings to Carlyle at an enterprise value of EUR 8.7 billion. The group will retain a 40% equity stake in Coatings, preserving upside potential while crystallizing value and simplifying the portfolio around core chemical and solutions activities.

Cash flow improves, balance sheet remains solid

Despite a tougher earnings backdrop, free cash flow improved by about EUR 600 million to EUR 1.3 billion while operating cash flow reached EUR 5.6 billion. Net debt fell to EUR 18.3 billion and the equity ratio held at 45.1%, giving BASF some balance sheet flexibility even as markets stay volatile and capex commitments remain significant.

Cost savings accelerated, but restructuring bill climbs

BASF lifted its cost-saving ambitions, reaching an annual reduction run rate of roughly EUR 1.7 billion by end-2025, EUR 100 million ahead of its earlier target. The company now aims for EUR 2.3 billion in annual savings by end-2026, but one-time restructuring costs have risen to a projected EUR 1.9 billion in total, with EUR 700 million booked in 2025 alone.

Capex discipline tightens as macro risks loom

Capital discipline is a clear theme, with BASF cutting planned capex for 2026–2029 to EUR 13 billion, around 20% below last year’s four-year forecast and over 30% below the 2024–2027 plan. Spending will fall from EUR 4.0 billion in 2025 to roughly EUR 3.3 billion in 2026, with only about EUR 600 million still earmarked for Zhanjiang after heavy 2025 outlays.

Shareholder returns maintained despite softer earnings

Management aims to keep investors engaged through steady payouts, proposing a dividend of EUR 2.25 per share, implying a yield of roughly 5.1% on the year-end share price. Share buybacks are underway as well, with around EUR 355 million of stock repurchased by the end of 2025, signaling confidence despite cyclical headwinds.

EBITDA declines underscore margin and demand pressure

Group EBITDA before special items slipped to EUR 6.6 billion for 2025, with the fourth quarter particularly weak at EUR 1.0 billion versus EUR 1.4 billion a year earlier. Management cited lower margins and subdued demand, especially in the Chemicals segment, underscoring how pricing pressure and underutilized capacity continue to drag on profitability.

Sales hit by pricing and FX despite volume gains

Fourth-quarter sales fell sharply as strong negative currency effects and slightly lower prices offset modest volume growth, including a 13% volume increase in China. Prices were down in five of six segments, most notably Chemicals and Materials, illustrating how intense competition and oversupply are forcing BASF to sacrifice pricing power.

Currency swings add another drag on earnings

Foreign-exchange moves knocked about EUR 110 million off Q4 EBITDA before special items and reduced full-year EBITDA by roughly EUR 235 million. Management warned that FX headwinds could intensify in the first quarter of 2026 and shave up to EUR 200 million off EBITDA, adding another layer of uncertainty for near-term results.

China overcapacity weighs on new investments

While Zhanjiang is a strategic milestone, BASF acknowledged that China’s chemical market is suffering from overcapacity and harsh price competition. The company expects only gradual margin recovery and sees the new site as a short-term drag, with a meaningful positive earnings contribution deferred until at least 2027 as utilization improves.

Operating cash flow hit by trading positions

Operating cash flow declined to EUR 5.6 billion from EUR 6.9 billion primarily due to shifts in other operating assets linked to increased precious metal trading positions. This technical drag on cash generation highlights the complexity of BASF’s trading activities and their potential to sway reported cash metrics from year to year.

Social tensions around real-estate sales and job shifts

Restructuring is not only a financial story, as the announced sale of around 4,400 BASF-owned flats in Ludwigshafen sparked social and political concerns locally. Plans to move service-hub roles in IT, Finance, and HR to India and Malaysia add to uncertainty, with details and job numbers still pending and stakeholders watching closely.

Guidance: transitional 2026 with disciplined spending

For 2026, BASF guided EBITDA before special items of EUR 6.2–7.0 billion and free cash flow of EUR 1.5–2.3 billion, with payments for property, plant and equipment and intangibles of about EUR 3.4 billion. The company reiterated its EUR 13 billion capex envelope for 2026–2029 and expects Q1 FX headwinds to potentially cut EBITDA by up to EUR 200 million, framing 2026 as a year of consolidation.

BASF’s earnings call left investors weighing solid strategic execution against a stubbornly weak cycle and mounting restructuring costs. The group is shrinking capex, lifting savings targets, and maintaining an attractive dividend, yet acknowledges that 2026 will be a grind as markets stay soft, China remains oversupplied, and currency volatility continues to test margins and cash flow.